Study finds higher death rates among UK cancer patients following COVID-19 diagnosis
Cancer patients from the UK were 1.5 times more likely to die following a diagnosis with COVID-19 than cancer patients from European countries.
This is the finding of a study of over 1000 patients - 924 from European countries and 468 from the UK - during the first wave of the COVID-19 pandemic. The research team, led by Imperial College London, say the study highlights the need for UK cancer patients to be prioritized for vaccination.
The study tracked data between 27 February to 10 September 2020, across 27 centres in six countries: Italy, Spain, France, Belgium, Germany and the UK.
Loading video.
VIDEO: Alessio Cortellini, M.D., is the recipient of the 2020 Young Investigator Award (YIA) presented by The Oncologist. Launched in 2018, the award was established to honor a promising young physician. view more
Credit: AlphaMed Press
Durham, NC - Alessio Cortellini, M.D., was awarded
The Oncologist s 3rd Annual Young Investigator Award for his research on evaluating the risk of immunotherapy treatment to patients with pre-existing autoimmune disease.
The Oncologist journal established this award to foster advancements in the field of oncology by honoring a young researcher who is principal author of a high-impact article with the greatest potential to improve patient outcomes.